Patheon Recognized for Most Effective Scale-Up and Technical Transfer at the European Outsourcing Awards



    TORONTO, Oct. 2 /CNW/ - Patheon (TSX:PTI), a leading provider of contract
development and manufacturing services to the global pharmaceutical industry,
has won the European Outsourcing Award (EOA) in conjunction with Procter and
Gamble Pharmaceuticals at this year's event. Patheon has won in the category
of the Most Effective Scale-Up and Technical Transfer award. This honor is in
recognition of the impeccable work Patheon has provided with Procter and
Gamble Pharmaceuticals. Their strategic partnership has been very successful
and has demonstrated their effectiveness and reliability during a very
demanding technical transfer.
    Phill Slater, Director of External Supply Organization for Procter and
Gamble stated, "Patheon was selected as our partner in this project based on
their experience, capabilities in technology and quality management. With
Patheon, we could ensure we met the needs of our customers now and in the
future."
    Terry Novak, President of North America and Chief Marketing Officer,
stated, "Patheon is proud to have won the Most Effective Scale-Up and
Technical Transfer award at this year's European Outsourcing Awards. Our
performance in the industry is being recognized for a reason: we have
dedicated ourselves to understanding our customer's needs and developing both
the capability and capacity to deliver on those needs. It's rewarding to even
be considered with Procter and Gamble for this award by other industry
leaders."
    Launched in 2005, the European Outsourcing Awards recognizes significant
developments in Contract Services and rewards successful companies for their
outstanding contributions and achievements throughout the year. The awards
were created to celebrate and recognize excellence in R&D, marketing,
business, and technology across the pharmaceutical industry. This year's event
took place in Frankfurt, Germany on October 1st, during the CPhI (Convention
of Pharmaceutical Ingredients) trade show and conference. Additional
categories awarded include: Best New Product, Best Contract Manufacturing
Project, and Most Outstanding Applications in Generics.

    ABOUT PATHEON

    Patheon Inc. (TSX:PTI; www.patheon.com) is a leading global provider of
contract development and manufacturing services to the global pharmaceutical
industry. Patheon prides itself in providing the highest quality products and
services to more than 300 of the world's leading pharmaceutical and
biotechnology companies. Patheon's services range from preclinical development
through commercial manufacturing of a full array of dosage forms including
parenteral, solid, semi-solid and liquid forms. Patheon uses many innovative
technologies including single-use disposables, Liquid-Filled Hard Capsules and
a variety of modified release technologies.
    Patheon's comprehensive range of fully integrated Pharmaceutical
Development Services includes pre-formulation, formulation, analytical
development, clinical manufacturing, scale-up and commercialization. Patheon
can take customers direct to clinic with global clinical packaging and
distribution services and Patheon's Quick to Clinic(TM) programs can
accelerate early phase development project to clinical trials while minimizing
the consumption of valuable API. Patheon's integrated network strives to
ensure that customer products can be launched with confidence globally.

    Caution Concerning Forward-Looking Statements

    This news release may contain forward-looking statements which reflect
management's expectations regarding the Company's future growth of operations,
performance (both operational and financial) and business prospects and
opportunities. These statements are made in the context of the risks and
uncertainties that are outlined in the Company's public documents, which can
be accessed on our website at www.patheon.com or on SEDAR at www.sedar.com.

    %SEDAR: 00001700E




For further information:

For further information: Mr. Wes Wheeler, President & Chief Executive
Officer, Tel: (905) 812-2112, Email: wes.wheeler@patheon.com; Mr. Eric Evans,
Chief Financial Officer, Tel: (905) 812-6660, Email: eric.evans@patheon.com;
Ms. Jean Treadwell, Investor Relations, Tel: (905) 816-8344, Email:
jean.treadwell@patheon.com

Organization Profile

Patheon Inc

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890